Ledipasvir and Sofosbuvir for 8 or 12 Weeks for Chronic HCV without CirrhosisKris V. Kowdley, Michael Fried, Robert H. Hyland et al.|New England Journal of Medicine|2014Cited by 1.1k
Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver DiseaseMichael Charlton, Atif Zaman, Gregory T. Everson et al.|Gastroenterology|2015Cited by 799
World Gastroenterology Organisation Global Guidelines on Celiac DiseaseJulio C. Bai, Anton LeMair, Michael Fried et al.|Journal of Clinical Gastroenterology|2013Cited by 266
World Gastroenterology Organisation Global Guidelines Irritable Bowel SyndromeEamonn M.M. Quigley, Anton LeMair, Michael Fried et al.|Journal of Clinical Gastroenterology|2016Cited by 127
Interferon‐free therapy for genotype 1 hepatitis C in liver transplant recipients: Real‐world experience from the hepatitis C therapeutic registry and research networkRobert S. Brown, Norah A. Terrault, Jacqueline G. O’Leary et al.|Liver Transplantation|2015Cited by 105